Atherosclerosis
Volume 204, Issue 2 , Pages 503-508 , June 2009

Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events

  • Marit D. Solbu

      Affiliations

    • Department of Nephrology, University Hospital of North Norway, Tromsø, Norway
    • Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • Corresponding Author InformationCorresponding author at: Department of Nephrology, University Hospital of North Norway, N-9038 Tromsø, Norway. Tel.: +47 776 26000; fax: +47 776 69408.
    • ,
  • Jens Kronborg

      Affiliations

    • Department of Nephrology, Innlandet Hospital Trust, Lillehammer, Norway
    • Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • ,
  • Trond G. Jenssen

      Affiliations

    • Department of Nephrology, Rikshospitalet, National University Hospital, Oslo, Norway
    • Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • ,
  • Inger Njølstad

      Affiliations

    • Institute of Community Medicine, University of Tromsø, Tromsø, Norway
    • ,
  • Maja-Lisa Løchen

      Affiliations

    • Institute of Community Medicine, University of Tromsø, Tromsø, Norway
    • Department of Cardiology, University Hospital of North Norway, Tromsø, Norway
    • ,
  • Ellisiv B. Mathiesen

      Affiliations

    • Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • Department of Neurology, University Hospital of North Norway, Tromsø, Norway
    • ,
  • Tom Wilsgaard

      Affiliations

    • Institute of Community Medicine, University of Tromsø, Tromsø, Norway
    • ,
  • Bjørn O. Eriksen

      Affiliations

    • Department of Nephrology, University Hospital of North Norway, Tromsø, Norway
    • Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • ,
  • Ingrid Toft

      Affiliations

    • Department of Nephrology, University Hospital of North Norway, Tromsø, Norway
    • Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway

Received 10 September 2008 ,Revised 21 October 2008 ,Accepted 2 November 2008.

References 

  1. National Kidney Foundation . KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S46–S76
  2. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310:356–360
  3. Ljungman S, Wikstrand J, Hartford M, Berglund G. Urinary albumin excretion—a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens. 1996;9:770–778
  4. Arnlov J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112:969–975
  5. Jørgensen L, Jenssen T, Heuch I, Jacobsen BK. The combined effect of albuminuria and inflammation on all-cause and cardiovascular mortality in non-diabetic persons. J Intern Med. 2008;264:493–501
  6. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–1782
  7. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245–1250
  8. Gale EA. The myth of the metabolic syndrome. Diabetologia. 2005;48:1679–1683
  9. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter?. Circulation. 2007;115:1806–1811
  10. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167–174
  11. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553
  12. Jager A, Kostense PJ, Nijpels G, et al. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia. 1998;41:694–700
  13. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442–443
  14. Kronborg J, Solbu M, Njolstad I, et al. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant. 2008;23:2818–2826
  15. Levey AS, Coresh J, Greene T, et al. Expressing the MDRD study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values. J Am Soc Nephrol. 2005;16:69A;[abstract]
  16. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–1062
  17. WHO MONICA Project Principal Investigators. The world health organization monica project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol. 1988;41:105–114
  18. Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 2003;108:2543–2549
  19. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689
  20. Klausen KP, Parving HH, Scharling H, Jensen JS. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J Intern Med. 2007;262:470–478
  21. Ingelsson E, Sullivan LM, Murabito JM, et al. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes. 2007;56:1718–1726
  22. Solbu MD, Kronborg J, Eriksen BO, Jenssen TG, Toft I. Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: A gender-specific follow-up study. Atherosclerosis. 2008;201:398–406
  23. National Cholesterol Education Program: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.
  24. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769–1778
  25. Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145:237–246
  26. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006;17:2100–2105
  27. Russo LM, Comper WD, Osicka TM. Mechanism of albuminuria associated with cardiovascular disease and kidney disease. Kidney Int Suppl. 2004;S67–S68
  28. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2006;113:e873–e923
  29. Cao JJ, Barzilay JI, Peterson D, et al. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: The Cardiovascular Health Study. Atherosclerosis. 2006;187:372–377
  30. Holme I, Sogaard AJ, Haheim LL, Larsen PGL, Tonstad S. Repeated weight loss is associated with the metabolic syndrome and diabetes: results of a 28 year re-screening of men in the Oslo Study. Metab Syndrome Relat Disord. 2007;5:127–135

PII: S0021-9150(08)00780-6

doi: 10.1016/j.atherosclerosis.2008.11.002

Atherosclerosis
Volume 204, Issue 2 , Pages 503-508 , June 2009

Article Tools

* Image Usage & Resolution